ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Fitzgerald Kevin Joseph โ CSO & EVP, Head of Research
Shares
359
Price
$321.58
Total Value
$115,447.22
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Fitzgerald Kevin Joseph |
|---|---|
| Title | CSO & EVP, Head of Research |
| Transaction Date | Mar 3, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 5, 2026 |
| Shares Sold | 359 |
| Price per Share | $321.58 |
| Total Value | $115,447.22 |
| Shares Owned After | 21,860 |
| Derivative | No |
| Accession Number | 0001735276-26-000051 |
| Document | View SEC Filing |